메뉴 건너뛰기




Volumn 7, Issue SUPPL. 1, 2009, Pages 239-244

Development of thrombopoietin receptor agonists for clinical use

Author keywords

Animal model (NOG mice); Mimetics; Thrombocytopenia; Thrombopoeitin (TPO) receptor; TPO

Indexed keywords

ALPHA INTERFERON; AZACITIDINE; ELTROMBOPAG; HEMOSTATIC AGENT; NPLATE; PLACEBO; PROTEIN ANTIBODY MA01G4344U; RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; ROMIPLOSTIM; RWJ 800088; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY VB22B; STEROID; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR; THROMBOPOIETIN RECEPTOR AGONIST; UNCLASSIFIED DRUG;

EID: 67849104655     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03440.x     Document Type: Review
Times cited : (26)

References (47)
  • 1
    • 0032505102 scopus 로고    scopus 로고
    • Thrombopoietin
    • Kaushansky K. Thrombopoietin. N Engl J Med 1998; 339: 746-54.
    • (1998) N Engl J Med , vol.339 , pp. 746-754
    • Kaushansky, K.1
  • 2
    • 0042914309 scopus 로고    scopus 로고
    • Long-term administration of pegylated recombinant human megakaryocyte growth and development factor dramatically improved cytopenias in a patient with myelodysplastic syndrome
    • Kizaki M, Miyakawa Y, Ikeda Y. Long-term administration of pegylated recombinant human megakaryocyte growth and development factor dramatically improved cytopenias in a patient with myelodysplastic syndrome. Br J Haematol 2003; 122: 764-7.
    • (2003) Br J Haematol , vol.122 , pp. 764-767
    • Kizaki, M.1    Miyakawa, Y.2    Ikeda, Y.3
  • 3
    • 38949153807 scopus 로고    scopus 로고
    • Historical review: Megakaryopoiesis and thrombopoiesis
    • Kaushansky K. Historical review: Megakaryopoiesis and thrombopoiesis. Blood 2008; 111: 981-6.
    • (2008) Blood , vol.111 , pp. 981-986
    • Kaushansky, K.1
  • 4
    • 34249733156 scopus 로고    scopus 로고
    • New thrombopoietic growth factors
    • Kuter DJ. New thrombopoietic growth factors. Blood 2007; 109: 4607-16.
    • (2007) Blood , vol.109 , pp. 4607-4616
    • Kuter, D.J.1
  • 5
    • 0036530040 scopus 로고    scopus 로고
    • Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor
    • Basser RL, O'Flaherty E, Green M, Edmonds M, Nichol J, Menchaca DM, Cohen B, Begley CG. Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood 2002; 99: 2599-602.
    • (2002) Blood , vol.99 , pp. 2599-2602
    • Basser, R.L.1    O'Flaherty, E.2    Green, M.3    Edmonds, M.4    Nichol, J.5    Menchaca, D.M.6    Cohen, B.7    Begley, C.G.8
  • 6
    • 0035760892 scopus 로고    scopus 로고
    • Thrombocytopenia caused by the development of antibodies to thrombopoietin
    • Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M, Kuter DJ. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 2001; 98: 3241-8.
    • (2001) Blood , vol.98 , pp. 3241-3248
    • Li, J.1    Yang, C.2    Xia, Y.3    Bertino, A.4    Glaspy, J.5    Roberts, M.6    Kuter, D.J.7
  • 8
    • 0037100423 scopus 로고    scopus 로고
    • Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura
    • Nomura S, Dan K, Hotta T, Fujimura K, Ikeda Y. Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura. Blood 2002; 100: 728-30.
    • (2002) Blood , vol.100 , pp. 728-730
    • Nomura, S.1    Dan, K.2    Hotta, T.3    Fujimura, K.4    Ikeda, Y.5
  • 9
    • 0032227226 scopus 로고    scopus 로고
    • Endogenous TPO (eTPO) levels in health and disease: Possible clues for therapeutic intervention
    • Nichol JL. Endogenous TPO (eTPO) levels in health and disease: Possible clues for therapeutic intervention. Stem Cells 1998; 16 (Suppl. 2): 165-75.
    • (1998) Stem Cells , vol.16 , Issue.SUPPL. 2 , pp. 165-175
    • Nichol, J.L.1
  • 10
    • 0842328846 scopus 로고    scopus 로고
    • Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP
    • McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 2004; 103: 1364-9.
    • (2004) Blood , vol.103 , pp. 1364-1369
    • McMillan, R.1    Wang, L.2    Tomer, A.3    Nichol, J.4    Pistillo, J.5
  • 14
    • 60249099882 scopus 로고    scopus 로고
    • Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: A randomised, double-blind, placebo-controlled trial
    • Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L, Salama A, Jenkins JM, Roychowdhury D, Mayer B, Stone N, Arning M. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: A randomised, double-blind, placebo-controlled trial. Lancet 2009; 373: 641-8.
    • (2009) Lancet , vol.373 , pp. 641-648
    • Bussel, J.B.1    Provan, D.2    Shamsi, T.3    Cheng, G.4    Psaila, B.5    Kovaleva, L.6    Salama, A.7    Jenkins, J.M.8    Roychowdhury, D.9    Mayer, B.10    Stone, N.11    Arning, M.12
  • 16
    • 34648847269 scopus 로고    scopus 로고
    • Single and multiple oral doses of AKR-501 (YM477) increase the platelet count in healthy volunteers
    • [ASH Annual Meeting Abstracts]
    • Desjardins RE, Tempel DL, Lucek R, Kuter DJ. Single and multiple oral doses of AKR-501 (YM477) increase the platelet count in healthy volunteers [ASH Annual Meeting Abstracts]. Blood 2006; 108: 477.
    • (2006) Blood , vol.108 , pp. 477
    • Desjardins, R.E.1    Tempel, D.L.2    Lucek, R.3    Kuter, D.J.4
  • 17
    • 67849083635 scopus 로고    scopus 로고
    • Clinical characterization of a novel oral thrombopoietin mimetic LGD-4665 in healthy volunteers demonstrate safe and sustained increases in platelet counts with flexible dosing choices for phase II trials
    • [ASH Annual Meeting Abstracts]
    • Dziewanowska ZE, Kapil RP, Zhang JK, Berg JK, Stevens VJ, Matsumoto RM, Greenberg L, Morris MY. Clinical characterization of a novel oral thrombopoietin mimetic LGD-4665 in healthy volunteers demonstrate safe and sustained increases in platelet counts with flexible dosing choices for phase II trials [ASH Annual Meeting Abstracts]. Blood 2008; 112: 3406.
    • (2008) Blood , vol.112 , pp. 3406
    • Dziewanowska, Z.E.1    Kapil, R.P.2    Zhang, J.K.3    Berg, J.K.4    Stevens, V.J.5    Matsumoto, R.M.6    Greenberg, L.7    Morris, M.Y.8
  • 23
    • 0035951790 scopus 로고    scopus 로고
    • Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes
    • Miyakawa Y, Rojnuckarin P, Habib T, Kaushansky K. Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes. J Biol Chem 2001; 276: 2494-502.
    • (2001) J Biol Chem , vol.276 , pp. 2494-2502
    • Miyakawa, Y.1    Rojnuckarin, P.2    Habib, T.3    Kaushansky, K.4
  • 24
    • 31044439372 scopus 로고    scopus 로고
    • The molecular mechanisms that control thrombopoiesis
    • Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005; 115: 3339-47.
    • (2005) J Clin Invest , vol.115 , pp. 3339-3347
    • Kaushansky, K.1
  • 25
    • 0346881171 scopus 로고    scopus 로고
    • AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl
    • Broudy VC, Lin NL. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine 2004; 25: 52-60.
    • (2004) Cytokine , vol.25 , pp. 52-60
    • Broudy, V.C.1    Lin, N.L.2
  • 28
    • 34347210686 scopus 로고    scopus 로고
    • NMR structural studies of interactions of a small, nonpeptidyl Tpo mimic with the thrombopoietin receptor extracellular juxtamembrane and transmembrane domains
    • Kim MJ, Park SH, Opella SJ, Marsilje TH, Michellys PY, Seidel HM, Tian SS. NMR structural studies of interactions of a small, nonpeptidyl Tpo mimic with the thrombopoietin receptor extracellular juxtamembrane and transmembrane domains. J Biol Chem 2007; 282: 14253-61.
    • (2007) J Biol Chem , vol.282 , pp. 14253-14261
    • Kim, M.J.1    Park, S.H.2    Opella, S.J.3    Marsilje, T.H.4    Michellys, P.Y.5    Seidel, H.M.6    Tian, S.S.7
  • 31
    • 21344460746 scopus 로고    scopus 로고
    • The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis
    • Rios R, Sangro B, Herrero I, Quiroga J, Prieto J. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. Am J Gastroenterol 2005; 100: 1311-16.
    • (2005) Am J Gastroenterol , vol.100 , pp. 1311-1316
    • Rios, R.1    Sangro, B.2    Herrero, I.3    Quiroga, J.4    Prieto, J.5
  • 34
    • 37149046846 scopus 로고    scopus 로고
    • Evaluating safety and efficacy of AMG 531 for the treatment of thrombocytopenic patients with myelodysplastic syndrome (MDS): Preliminary results of a phase 1/2 study
    • [ASCO Annual Meeting Abstracts]
    • Kantarjian HM, Giles FJ, Fenaux P, Becker PS, Boruchov AM, Bowen DT, Hellström-Lindberg E, Larson RA, Lyons RM, Muus P. Evaluating safety and efficacy of AMG 531 for the treatment of thrombocytopenic patients with myelodysplastic syndrome (MDS): Preliminary results of a phase 1/2 study [ASCO Annual Meeting Abstracts]. J Clin Oncol 2007; 25 (Suppl. 18): 7032.
    • (2007) J Clin Oncol , vol.25 , Issue.SUPPL. 18 , pp. 7032
    • Kantarjian, H.M.1    Giles, F.J.2    Fenaux, P.3    Becker, P.S.4    Boruchov, A.M.5    Bowen, D.T.6    Hellström-Lindberg, E.7    Larson, R.A.8    Lyons, R.M.9    Muus, P.10
  • 35
    • 66749128758 scopus 로고    scopus 로고
    • Effect of romiplostim in patients (pts) with low or intermediate risk myelodysplastic syndrome (MDS) receiving Azacytidine [ASH Annual Meeting Abstracts]
    • Kantarjian H, Giles F, Greenberg P, Paquette R, Wang E, Gabrilove J, Garcia-Manero G, Gray J, Hu K, Franklin J. Effect of romiplostim in patients (pts) with low or intermediate risk myelodysplastic syndrome (MDS) receiving Azacytidine [ASH Annual Meeting Abstracts]. Blood 2008; 112: 224.
    • (2008) Blood , vol.112 , pp. 224
    • Kantarjian, H.1    Giles, F.2    Greenberg, P.3    Paquette, R.4    Wang, E.5    Gabrilove, J.6    Garcia-Manero, G.7    Gray, J.8    Hu, K.9    Franklin, J.10
  • 36
    • 33747339258 scopus 로고    scopus 로고
    • Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: Associations with impaired platelet production and increased platelet turnover
    • Yamazaki R, Kuwana M, Mori T, Okazaki Y, Kawakami Y, Ikeda Y, Okamoto S. Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: Associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant 2006; 38: 377-84.
    • (2006) Bone Marrow Transplant , vol.38 , pp. 377-384
    • Yamazaki, R.1    Kuwana, M.2    Mori, T.3    Okazaki, Y.4    Kawakami, Y.5    Ikeda, Y.6    Okamoto, S.7
  • 39
    • 0030945262 scopus 로고    scopus 로고
    • Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets
    • Miyakawa Y, Oda A, Druker BJ, Ozaki K, Handa M, Ohashi H, Ikeda Y. Thrombopoietin and thrombin induce tyrosine phosphorylation of Vav in human blood platelets. Blood 1997; 89: 2789-98.
    • (1997) Blood , vol.89 , pp. 2789-2798
    • Miyakawa, Y.1    Oda, A.2    Druker, B.J.3    Ozaki, K.4    Handa, M.5    Ohashi, H.6    Ikeda, Y.7
  • 40
    • 10544225380 scopus 로고    scopus 로고
    • Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin
    • Oda A, Miyakawa Y, Druker BJ, Ishida A, Ozaki K, Ohashi H, Wakui M, Handa M, Watanabe K, Okamoto S, Ikeda Y. Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin. Blood 1996; 88: 4304-13.
    • (1996) Blood , vol.88 , pp. 4304-4313
    • Oda, A.1    Miyakawa, Y.2    Druker, B.J.3    Ishida, A.4    Ozaki, K.5    Ohashi, H.6    Wakui, M.7    Handa, M.8    Watanabe, K.9    Okamoto, S.10    Ikeda, Y.11
  • 41
    • 0030052617 scopus 로고    scopus 로고
    • Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets
    • Miyakawa Y, Oda A, Druker BJ, Miyazaki H, Handa M, Ohashi H, Ikeda Y. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets. Blood 1996; 87: 439-46.
    • (1996) Blood , vol.87 , pp. 439-446
    • Miyakawa, Y.1    Oda, A.2    Druker, B.J.3    Miyazaki, H.4    Handa, M.5    Ohashi, H.6    Ikeda, Y.7
  • 42
    • 0029052479 scopus 로고
    • Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets
    • Miyakawa Y, Oda A, Druker BJ, Kato T, Miyazaki H, Handa M, Ikeda Y. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood 1995; 86: 23-7.
    • (1995) Blood , vol.86 , pp. 23-27
    • Miyakawa, Y.1    Oda, A.2    Druker, B.J.3    Kato, T.4    Miyazaki, H.5    Handa, M.6    Ikeda, Y.7
  • 45
    • 66749122752 scopus 로고    scopus 로고
    • Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia
    • Kuter DJ. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med 2009; 60: 193-206.
    • (2009) Annu Rev Med , vol.60 , pp. 193-206
    • Kuter, D.J.1
  • 47
    • 50949114155 scopus 로고    scopus 로고
    • Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes
    • Yamane A, Nakamura T, Suzuki H, Ito M, Ohnishi Y, Ikeda Y, Miyakawa Y. Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes. Blood 2008; 112: 542-50.
    • (2008) Blood , vol.112 , pp. 542-550
    • Yamane, A.1    Nakamura, T.2    Suzuki, H.3    Ito, M.4    Ohnishi, Y.5    Ikeda, Y.6    Miyakawa, Y.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.